跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LEVOFLOXACIN KABI SOLUTION FOR INFUSION 5MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
LEVOFLOXACIN KABI SOLUTION FOR INFUSION 5MG/ML
Approved
THERAPEUTIC
LEVOFLOXACIN KABI SOLUTION FOR INFUSION 5MG/ML
Fresenius Kabi Poland Sp. z.o.o
🇸🇬 Health Sciences Authority
Approval Date
Apr 20, 2017
Approval ID
a1f63e4b05a318b2
Company
Fresenius Kabi Poland Sp. z.o.o
Type
Therapeutic
Approval Details
Approval Id
a1f63e4b05a318b2
Drug Name
LEVOFLOXACIN KABI SOLUTION FOR INFUSION 5MG/ML
Product Name
LEVOFLOXACIN KABI SOLUTION FOR INFUSION 5MG/ML
Approval Number
SIN15218P
Approval Date
2017-04-20
Registrant
FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder
FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INFUSION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01MA12
Atc Item Name
levofloxacin
Pharma Manufacturer Name
FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path
/organization/fresenius-kabi-singapore-pte-ltd
Active Ingredients
Levofloxacin hemihydrate 5.1246 mg/ml equivalent levofloxacin
5mg/ml
LEVOFLOXACIN HEMIHYDRATE 5.1246 MG/ML EQUIVALENT LEVOFLOXACIN
5 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 20, 2017
Approval ID
a1f63e4b05a318b2
Type
Therapeutic
Back to HSA Approvals
